Medtox Scientific Stock Gaps Up On Today's Open (MTOX)
NEW YORK (TheStreet) -- Shares of Medtox Scientific (Nasdaq:MTOX) were gapping up Monday morning with an open price 35.2% higher than Friday's closing price. The stock closed at $19.70 Friday and opened today's trading at $26.63. The average volume for Medtox Scientific has been 31,900 shares per day over the past 30 days. Medtox Scientific has a market cap of $181.3 million and is part of the health care sector and health services industry. Shares are up 40.2% year to date as of the close of trading on Friday. MEDTOX Scientific, Inc., together with its subsidiaries, provides forensic and clinical laboratory services, and offers diagnostic devices. Its Laboratory Services segment offers drugs-of-abuse testing services. The company has a P/E ratio of 34.8, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Medtox Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Medtox Scientific Ratings Report. Get more investment ideas from our investment research center.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV